26.04.2018
SHOP APOTHEKE EUROPE N.V. NL0012044747
DGAP-News: SHOP APOTHEKE EUROPE N.V.: Annual General Meeting welcomes European growth strategy.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): AGM/EGM
SHOP APOTHEKE EUROPE N.V.: Annual General Meeting welcomes European growth
strategy.
26.04.2018 / 12:52
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
NOT FOR RELEASE OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN.
SHOP APOTHEKE EUROPE N.V.: Annual General Meeting welcomes European growth
strategy.
* Review of the successful financial year 2017.
* Agenda items approved by large majorities.
Venlo, 26 April 2018. Today's Annual General Meeting of SHOP APOTHEKE EUROPE
N.V. promoted the growth course of Europe's leading online pharmacy. A total
of 58.66% of the share capital was represented. This corresponds to
7,051,450 shares. As part of their presentation, the members of the
Management Board reviewed the financial year 2017 and gave a positive
outlook for the financial year 2018 to the shareholders. The Annual General
Meeting approved the agenda items proposed by the management with large
majorities.
Michael Köhler, CEO of SHOP APOTHEKE EUROPE N.V., comments: "The strong
support by our shareholders is a valid confirmation of our success story,
both operationally and strategically".
After a compelling first quarter 2018, in which the Group more than doubled
its sales volume compared to the same period last year, the Management Board
has reaffirmed its ambitious growth targets for the current year. "We are
targeting a further substantial revenue increase in 2018 and at the same
time pursue our profitable growth guidance", CFO Dr. Ulrich Wandel adds.
For the full year 2018, SHOP APOTHEKE EUROPE is budgeting an increase in
group revenues of 87% to 97% to EUR 530 m to 560 m as well as a positive
EBITDA (before one-off costs) at group level of EUR 0 to 2 m.
Further information about the Annual General Meeting can be found in the
Investor Relations section of the company's website
www.shop-apotheke-europe.com.
ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is the leading and fastest growing online pharmacy in
Continental Europe. SHOP APOTHEKE EUROPE already operates online pharmacies
in Germany, Austria, France, Belgium, Italy, Spain and the Netherlands. In
Germany, the TÜV-certified shop-apotheke.com is the market leading. SHOP
APOTHEKE EUROPE delivers a broad range of more than 100,000 original
products to about 2.8 million active customers quickly and at attractive
prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive and
consistent pharmaceutical services. SHOP APOTHEKE EUROPE N.V. has been
listed on the regulated market of the Frankfurt Stock Exchange (Prime
Standard) since 13 October 2016.
MEDIA CONTACTS.
Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: [email protected]
Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: [email protected]
Investor Relations:
Dr. Ulrich Wandel
Telephone: +31 77 850 6117
Email: [email protected]
DISCLAIMER.
This publication is an advertisement.
This communication constitutes neither an offer to sell nor a solicitation
to buy securities of Shop Apotheke Europe N.V. in any jurisdiction. This is
not a securities prospectus. No public offering of any securities of Shop
Apotheke Europe N.V. is being made.
Statements contained herein may constitute "forward-looking statements."
Forward-looking statements are generally identifiable by the use of the
words "may", "will", "should", "plan", "expect", "anticipate", "estimate,"
"believe", "intend", "project", "goal" or "target" or the negative of these
words or other variations on these words or comparable terminology.
Forward-looking statements are based on current expectations and involve a
number of known and unknown risks, uncertainties and other factors that
could cause the Group's or its industry's actual results, levels of
activity, performance or achievements to be materially different from any
future results, levels of activity, performance or achievements expressed or
implied by such forward-looking statements. You should not place undue
reliance on forward-looking statements and the Group does not undertake
publicly to update or revise any forward-looking statement that may be made
herein, whether as a result of new information, future events or otherwise.
---------------------------------------------------------------------------
26.04.2018 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
679719 26.04.2018
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
SHOP APOTHEKE EUROPE N.V. ISIN: NL0012044747 können Sie bei EQS abrufen
E-Commerce , A2AR94 , RDC , XETR:RDC